North America Insulin Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Insulin Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Insulin Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Insulin Market Regional Analysis

6.2 North America Insulin Market Revenue 2020-2028 (US$ Million)

6.3 North America Insulin Market Forecast Analysis

7. North America Insulin Market Analysis – by Type

7.1 Long Acting Insulin

7.1.1 Overview
7.1.2 Long Acting Insulin: North America Insulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Rapid Acting Insulins

7.2.1 Overview
7.2.2 Rapid Acting Insulins: North America Insulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.3 Short acting Insulins and Traditional Human Insulins

7.3.1 Overview
7.3.2 Short acting Insulins and Traditional Human Insulins: North America Insulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.4 Concentrated Insulins and Combination Insulins

7.4.1 Overview
7.4.2 Concentrated Insulins and Combination Insulins: North America Insulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.5 Biosimilar Insulins

7.5.1 Overview
7.5.2 Biosimilar Insulins: North America Insulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.6 Glucagon-like peptide-1

7.6.1 Overview
7.6.2 Glucagon-like peptide-1: North America Insulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.7 Pens and Needles

7.7.1 Overview
7.7.2 Pens and Needles: North America Insulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. North America Insulin Market – North America Analysis

8.1 Overview

8.2 North America

8.2.1 North America Insulin Market Breakdown, by Key Country, 2023 and 2028 (%)
8.2.1.1 North America Insulin Market – Revenue and Forecast Analysis – by Country
8.2.1.1 US: North America Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.1.1.1 US: North America Insulin Market Breakdown, by Type

8.2.1.2 Canada: North America Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.1.2.1 Canada: North America Insulin Market Breakdown, by Type

8.2.1.3 Mexico : North America Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.1.3.1 Mexico : North America Insulin Market Breakdown, by Type

9. Competitive Landscape

9.1 Heat Map Analysis

9.2 Company Positioning and Concentration

10. Industry Landscape

10.1 Overview

10.2 Market Initiative

10.3 Partnerships and Collaborations

10.4 Other Developments

11. Company Profiles

11.1 Biocon

11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments

11.2 Eli Lilly and Company

11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments

11.3 GlaxoSmithKline plc.

11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments

11.4 Merck & Co., Inc.

11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments

11.5 Novo Nordisk A/S

11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments

11.6 Pfizer Inc.

11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments

11.7 Sanofi

11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments

11.8 Tonghua Dongbao Pharmaceutical Co., Ltd.

11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments

11.9 Wockhardt

11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments

12. Appendix

12.1 About Business Market Insights

12.2 List of Abbreviations

North America Insulin Market

Analysis – by Type [Long Acting Insulin, Rapid Acting Insulins, Short-Acting Insulins and Traditional Human Insulins, Concentrated Insulins and Combination Insulins, Biosimilar Insulins, Glucagon-Like Peptide-1 (GLP-1), Pens and Needles, and Others]